244 related articles for article (PubMed ID: 2180104)
1. [Graft rejection reaction and immunosuppression following heart transplantation].
Leonardi L; Lüthy A; Mondada C; Waser M; Laske A; Turina M; Gallino A
Ther Umsch; 1990 Feb; 47(2):147-51. PubMed ID: 2180104
[TBL] [Abstract][Full Text] [Related]
2. Heart allograft rejection under varying immunosuppressive protocols as evaluated by endomyocardial biopsy.
Imakita M; Tazelaar HD; Billingham ME
J Heart Transplant; 1986; 5(4):279-85. PubMed ID: 3305819
[TBL] [Abstract][Full Text] [Related]
3. Utility of surveillance biopsies in infant heart transplant recipients.
Balzer DT; Moorhead S; Saffitz JE; Huddleston CB; Spray TL; Canter CE
J Heart Lung Transplant; 1995; 14(6 Pt 1):1095-101. PubMed ID: 8719456
[TBL] [Abstract][Full Text] [Related]
4. Prognostic determinants of six-month morbidity and mortality in heart transplant recipients. The Italian Study Group on Infection in Heart Transplantation.
De Maria R; Minoli L; Parolini M; Gavazzeni G; Gentile M; Grossi P; Livi U; Parisi F; Utili R
J Heart Lung Transplant; 1996 Feb; 15(2):124-35. PubMed ID: 8672515
[TBL] [Abstract][Full Text] [Related]
5. Mannose-binding lectin deficiency offers protection from acute graft rejection after heart transplantation.
Fildes JE; Shaw SM; Walker AH; McAlindon M; Williams SG; Keevil BG; Yonan N
J Heart Lung Transplant; 2008 Dec; 27(12):1353-6. PubMed ID: 19059118
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis, surveillance, and epidemiologic evaluation of viral infections in pediatric cardiac transplant recipients with the use of the polymerase chain reaction.
Schowengerdt KO; Ni J; Denfield SW; Gajarski RJ; Radovancevic B; Frazier HO; Demmler GJ; Kearney D; Bricker JT; Towbin JA
J Heart Lung Transplant; 1996 Feb; 15(2):111-23. PubMed ID: 8672514
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppression following cardiac transplantation.
Woodley SL; Renlund DG; O'Connell JB; Bristow MR
Cardiol Clin; 1990 Feb; 8(1):83-96. PubMed ID: 2407363
[TBL] [Abstract][Full Text] [Related]
8. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
Herzberg GZ; Rossi AF; Courtney M; Gelb BD
J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
[TBL] [Abstract][Full Text] [Related]
9. Effects of methotrexate on acute rejection and cardiac allograft vasculopathy in heart transplant recipients.
Costanzo MR; Koch DM; Fisher SG; Heroux AL; Kao WG; Johnson MR
J Heart Lung Transplant; 1997 Feb; 16(2):169-78. PubMed ID: 9059928
[TBL] [Abstract][Full Text] [Related]
10. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
Charlton M; Seaberg E
Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S107-14. PubMed ID: 10431024
[TBL] [Abstract][Full Text] [Related]
11. Management of rejection in heart transplant recipients: does moderate rejection always require treatment?
Hutter JA; Wallwork J; English TA
J Heart Transplant; 1990; 9(2):87-91. PubMed ID: 2319377
[TBL] [Abstract][Full Text] [Related]
12. Reversal of cardiac transplant rejection without massive immunosuppression.
Michler RE; Smith CR; Drusin RE; Reison DS; Hickey TJ; Lamb J; Reemtsma K; Rose EA
Circulation; 1986 Nov; 74(5 Pt 2):III68-71. PubMed ID: 3533317
[TBL] [Abstract][Full Text] [Related]
13. The University of California at Los Angeles heart transplantation experience.
Kobashigawa JA; Laks H; Wu G; Patel J; Moriguchi J; Hamilton M; Fonarow G; Fishbein M; Ardehali A
Clin Transpl; 2005; ():173-85. PubMed ID: 17424734
[TBL] [Abstract][Full Text] [Related]
14. Experimental and clinical allogeneic heart transplant rejection: correlations between histology and immune reactivity detected by cytokine messenger RNA.
Normann SJ; Peck AB; Staples ED; Salomon DR; Mills RM
J Heart Lung Transplant; 1996 Aug; 15(8):778-89. PubMed ID: 8878760
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of in vitro propagation of activated lymphocytes from endomyocardial biopsy samples of pediatric heart transplant recipients.
Webber SA; Bentlejewski C; Park A; Fricker FJ; Griffith C; Boyle GJ; Miller SA; Pham S; Murali S; Griffith BP; Duquesnoy R; Zeevi A
Pediatr Transplant; 1998 Aug; 2(3):200-5. PubMed ID: 10084743
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate for lung transplant recipients with steroid-resistant acute rejection.
Cahill BC; O'Rourke MK; Strasburg KA; Savik K; Jessurun J; Bolman RM; Hertz MI
J Heart Lung Transplant; 1996 Nov; 15(11):1130-7. PubMed ID: 8956122
[TBL] [Abstract][Full Text] [Related]
17. Advantages of C2 monitoring to avoid acute rejection in pediatric heart transplant recipients.
Schubert S; Abdul-Khaliq H; Lehmkuhl HB; Hübler M; Abd El Rahman MY; Miera O; Ewert P; Weng Y; Wei H; Krüdewagen B; Hetzer R; Berger F
J Heart Lung Transplant; 2006 Jun; 25(6):619-25. PubMed ID: 16730566
[TBL] [Abstract][Full Text] [Related]
18. Late acute cardiac allograft rejection: new therapeutic options?
Schweiger M; Wasler A; Prenner G; Tripolt M; Schwarz M; Tscheliessnigg KH
Transplant Proc; 2005 Dec; 37(10):4528-31. PubMed ID: 16387161
[TBL] [Abstract][Full Text] [Related]
19. Electric myocardial impedance registration in humoral rejection after heart transplantation.
Grauhan O; Müller J; Knosalla C; Cohnert T; Siniawski H; Volk HD; Fietze E; Kupetz W; Hetzer R
J Heart Lung Transplant; 1996 Feb; 15(2):136-43. PubMed ID: 8672516
[TBL] [Abstract][Full Text] [Related]
20. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]